LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $242,000 | +11.0% | 1,566 | 0.0% | 0.04% | 0.0% |
| Q3 2021 | $218,000 | +6.3% | 1,566 | 0.0% | 0.04% | +5.9% |
| Q2 2021 | $205,000 | -14.2% | 1,566 | 0.0% | 0.03% | -22.7% |
| Q1 2021 | $239,000 | +12.2% | 1,566 | 0.0% | 0.04% | -30.2% |
| Q4 2018 | $213,000 | -50.5% | 1,566 | 0.0% | 0.06% | -41.7% |
| Q3 2018 | $430,000 | +32.7% | 1,566 | 0.0% | 0.11% | +25.6% |
| Q2 2018 | $324,000 | +51.4% | 1,566 | 0.0% | 0.09% | +45.8% |
| Q4 2017 | $214,000 | +5.9% | 1,566 | -6.0% | 0.06% | +3.5% |
| Q2 2017 | $202,000 | -1.0% | 1,666 | -16.6% | 0.06% | -19.7% |
| Q3 2016 | $204,000 | -14.3% | 1,998 | 0.0% | 0.07% | -16.5% |
| Q2 2016 | $238,000 | +11.2% | 1,998 | 0.0% | 0.08% | +3.7% |
| Q1 2016 | $214,000 | -1.4% | 1,998 | 0.0% | 0.08% | -7.9% |
| Q4 2015 | $217,000 | -33.8% | 1,998 | -81.0% | 0.09% | -41.8% |
| Q1 2015 | $328,000 | – | 10,530 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |